SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CALO', Girolamo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.790
EU - Europa 5.113
AS - Asia 4.149
SA - Sud America 31
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 11
AF - Africa 2
Totale 33.111
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.697
CN - Cina 2.018
UA - Ucraina 1.380
SG - Singapore 1.042
DE - Germania 1.003
IT - Italia 894
TR - Turchia 867
GB - Regno Unito 693
FI - Finlandia 431
SE - Svezia 321
CA - Canada 92
PL - Polonia 87
BE - Belgio 85
ID - Indonesia 81
FR - Francia 57
RU - Federazione Russa 54
VN - Vietnam 49
CZ - Repubblica Ceca 27
IN - India 23
LT - Lituania 21
NL - Olanda 18
IR - Iran 16
BR - Brasile 15
HK - Hong Kong 14
JP - Giappone 12
CL - Cile 11
NZ - Nuova Zelanda 8
AU - Australia 7
A2 - ???statistics.table.value.countryCode.A2??? 6
AT - Austria 6
KR - Corea 6
EU - Europa 5
DK - Danimarca 4
IE - Irlanda 4
IQ - Iraq 4
AR - Argentina 3
GR - Grecia 3
HR - Croazia 3
LU - Lussemburgo 3
NO - Norvegia 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
CH - Svizzera 2
ES - Italia 2
SK - Slovacchia (Repubblica Slovacca) 2
YE - Yemen 2
AL - Albania 1
BD - Bangladesh 1
BS - Bahamas 1
DZ - Algeria 1
EC - Ecuador 1
EE - Estonia 1
IL - Israele 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
MC - Monaco 1
MD - Moldavia 1
MM - Myanmar 1
MY - Malesia 1
NP - Nepal 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
SA - Arabia Saudita 1
TH - Thailandia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 33.111
Salva come PNG Salva come JPEG
Città #
Fairfield 3.307
Woodbridge 2.890
Houston 1.957
Ashburn 1.622
Jacksonville 1.591
Ann Arbor 1.518
Chandler 1.392
Seattle 1.339
Wilmington 1.180
Cambridge 1.156
Santa Clara 1.036
Singapore 840
Izmir 546
Nanjing 456
Princeton 355
Beijing 352
Ferrara 304
San Diego 280
Boardman 263
Milan 198
New York 197
Shanghai 196
Helsinki 139
Nanchang 137
Shenyang 129
Dearborn 127
Los Angeles 123
Munich 98
Falls Church 92
Brussels 82
Warsaw 82
Hebei 81
Jakarta 81
San Mateo 81
Norwalk 78
Jiaxing 75
Bremen 74
Tianjin 74
London 73
Changsha 68
Redwood City 64
Mountain View 63
Jinan 58
Addison 48
Auburn Hills 48
Dong Ket 45
Kunming 43
Zhengzhou 43
Washington 42
Philadelphia 38
Toronto 37
Guangzhou 33
Mcallen 30
Montréal 29
Tappahannock 28
Des Moines 27
Ningbo 27
Orange 27
Bologna 26
Indiana 26
Fuzhou 20
Verona 20
Falkenstein 19
Brno 18
Frankfurt am Main 18
Lanzhou 18
Redmond 18
Leawood 17
Ottawa 17
Padova 17
Augusta 16
Hangzhou 15
Hounslow 12
Taizhou 12
Düsseldorf 10
Ardabil 9
Bari 8
Changchun 8
Florence 7
Hefei 7
Prescot 7
Walnut 7
Espoo 6
Ferrara di Monte Baldo 6
Hong Kong 6
Islington 6
Kilburn 6
Olomouc 6
San Francisco 6
Springfield 6
São Paulo 6
Amsterdam 5
Chicago 5
Chiswick 5
Clifton 5
Haikou 5
La Canada Flintridge 5
Monmouth Junction 5
Mumbai 5
Rome 5
Totale 25.850
Salva come PNG Salva come JPEG
Nome #
Chimeric G proteins in fluorimetric calcium assays: Experience with opioid receptors 247
AGONISTI PIENI E PARZIALI ED ANTAGONISTI DEL RECETTORE PER NOCICETTINA/ORFANINA FQ AD ELEVATA POTENZA” 213
null 205
A diastereoselective synthesis of Cebranopadol, a novel analgesic showing NOP/mu mixed agonism 178
Characterization of FR 172357, a new non-peptide bradykinin B2 receptor antagonist, in human, pig and rabbit preparations 175
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 171
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 168
Structural Bacterial Molecules as Potential Candidates for an Evolution of the Classical Concept of Probiotics 166
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 161
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide. 155
Kinin B-1 and B-2 receptors in pig vessels: characterization of two monoreceptor systems 154
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 153
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 150
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 148
Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111 147
A new selective antagonist of the nociceptin receptor 147
Structure activity studies of nociceptin/orphanin FQ(1–13)-NH2 derivatives modified in position 5 147
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor 145
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2 144
Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze. 143
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 143
Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity 140
Pharmacological profile of nociceptin/orphanin FQ receptors interacting with G-proteins and β-arrestins 2 140
Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic- versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands 140
Emergency admissions of opioid drug-abusers for overdose. A chronobiological study of enhanced risk 139
A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials 139
Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor 138
Pharmacological characterization of nociceptin receptor: an in vitro study 138
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 137
Ring size in cyclic endomorphin-2 analogs modulates receptor binding affinity and selectivity 137
Intrathecal administration of nociceptin/orphanin FQ receptor agonists in rats: A strategy to relieve chemotherapy-induced neuropathic hypersensitivity 137
Characterisation of the novel mixed Mu-NOP peptide ligand dermorphin-N/OFQ (DeNo) 137
Modulation of the NOP receptor signaling affects resilience to acute stress 137
Nociceptin/orphanin FQ induces simultaneously anxiolytic and amnesic effects in the mouse elevated T-maze task. 136
A new ligand for the urotensin II receptor 136
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S receptor: structure activity and pharmacological studies 136
Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist 135
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 135
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 135
Structure-and conformation-Activity studies of nociceptin/orphanin FQ receptor dimeric ligands 134
Effects of vasoactive agents in healthy and diseased human saphenous veins 133
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test 133
In vitro pharmacological characterisation of a novel cyclic nociceptin/orphanin FQ analogue c[Cys(7,10)]N/OFQ(1-13)NH2 131
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 131
Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems 131
Genetic and pharmacological evidence that endogenous nociceptin/orphanin FQ contributes to dopamine cell loss in Parkinson's disease 131
Genetic Deletion of the Nociceptin/Orphanin FQ Receptor in the Rat Confers Resilience to the Development of Drug Addiction 131
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 130
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 129
AMPA receptor activation regulates the glutamate metabotropic receptor stimulated phosphatidylinositol turnover in human cerebral cortex slices 129
Electrocardiographic alterations as a result of acute intoxication with fluvoxamine and pipamperone 127
Cardiovascular effects of nociceptin in unanesthetized mice 125
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 125
Synthesis of mixed MOR/KOR efficacy cyclic opioid peptide analogs with antinociceptive activity after systemic administration 125
Antidepressant activity of nociceptin/orphanin FQ receptor antagonists in the mouse learned helplessness 125
The Importance of Ligand-Receptor Conformational Pairs in Stabilization: Spotlight on the N/OFQ G Protein-Coupled Receptor 125
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 124
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 124
Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs. 124
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 124
[Nphe(1)]nociceptin-(1-13)-NH2 antagonizes nociceptin effects in the mouse colon 123
Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: In vitro and in vivo studies 123
Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands 123
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 123
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24. 123
In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403 123
Actual concept of "probiotics": is it more functional to science or business? 122
Pharmacological characterization of tachykinin tetrabranched derivatives 121
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11) 120
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists. 120
Selective breeding for high anxiety introduces a synonymous SNP that increases neuropeptide s receptor activity 120
Pharmacological characterization of the nociceptin receptor mediating hyperphagia: identification of a selective antagonist 119
[Nphe(1)]N/OFQ-(1-13)-NH2 is a competitive and selective antagonist at nociceptin/orphanin FQ receptors mediating K+ channel activation in rat periaqueductal gray slices 119
Nociceptin/orphanin FQ receptor knockout rats: In vitro and in vivo studies 119
Effects of neuropeptide S on seizures and oxidative damage induced by pentylenetetrazole in mice. 119
Effects of chronic nociceptin/orphanin FQ exposure on cAMP accumulation and receptor density in Chinese, hamster ovary cells expressing human nociceptin/orphanin FQ receptors 118
[Nphe(1)]nociceptin-(1-13)NH2 selectively antagonizes nociceptin effects in the rabbit isolated ileum 118
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies 118
Structure-activity study at positions 3 and 4 of human neuropeptide S. 118
Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist 118
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 117
Role of nociceptin/orphanin FQ receptors in the decrease of mucosal mast cells caused by acute stress in the rat colon. 116
In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1 116
Sudden death from pulmonary thromboembolism: chronobiological aspects 115
In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant 115
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 115
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 115
Assessment of the activity of a novel nociceptin/orphanin FQ analogue at recombinant human nociceptin/orphanin FQ receptors expressed in Chinese hamster ovary cells 114
Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120 114
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus 114
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): identification of a partial agonist of the UT receptor. 113
The effect of guanethidine and local anaesthetics on the electrically stimulated mouse vas deferens 112
Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex. 112
Pharmacological profile of hemokinin 1: a novel member of the tachykinin family 112
Inhibitory effect of NMDA receptor activation on quisqualate-stimulated phosphatidylinositol turnover in the human cerebral cortex 112
Neuropeptide S receptor ligands: a patent review (2005-2016) 112
Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors 112
Nociceptin/orphanin FQ inhibits ischaemia-induced glutamate efflux from rat cerebrocortical slices 111
Studies on the antinociceptive effect of [Nphe(1)]nociceptin(1-13)NH2 in mice 111
B1 and B2 kinin receptors in various species 111
Totale 13.299
Salva come PNG Salva come JPEG
Categoria #
all - tutte 160.570
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.934
Totale 163.504
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.238 0 0 0 0 0 872 748 783 660 653 331 191
2020/20214.830 378 445 264 570 307 489 167 567 154 634 577 278
2021/20223.644 144 369 312 217 203 190 217 236 156 302 313 985
2022/20233.455 379 160 114 414 572 485 177 315 470 21 196 152
2023/20241.781 196 229 88 50 99 310 74 142 35 30 53 475
2024/20252.863 183 203 631 254 864 728 0 0 0 0 0 0
Totale 33.582